Covered recipient · General Payments record
ADEKUNBI OBISESAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$973.30
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $316.64 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $95.91 | 5 |
| Amgen Inc. | $53.03 | 3 |
| Lilly USA, LLC | $42.66 | 2 |
| Biogen, Inc. | $41.68 | 2 |
| Exact Sciences Corporation | $22.59 | 1 |
| Abbott Laboratories | $22.12 | 1 |
| Inspire Medical Systems, Inc. | $21.07 | 1 |
| Merck Sharp & Dohme Corporation | $17.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.12 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124869700 | CMS |
| Amgen Inc. | $18.32 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643851 | CMS |
| Amgen Inc. | $18.47 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643853 | CMS |
| Amgen Inc. | $16.24 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643855 | CMS |
| Biogen, Inc. | $20.48 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104851734 | CMS |
| Biogen, Inc. | $21.20 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104834127 | CMS |
| Exact Sciences Corporation | $22.59 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114813660 | CMS |
| Inspire Medical Systems, Inc. | $21.07 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148164383 | CMS |
| Lilly USA, LLC | $18.95 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135489238 | CMS |
| Lilly USA, LLC | $23.71 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135489240 | CMS |
| Merck Sharp & Dohme LLC | $17.58 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141616136 | CMS |
| Novo Nordisk Inc | $16.83 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100252600 | CMS |
| Novo Nordisk Inc | $19.47 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100410381 | CMS |
| Novo Nordisk Inc | $19.85 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100289364 | CMS |
| Novo Nordisk Inc | $17.20 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100333045 | CMS |
| Novo Nordisk Inc | $22.56 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100227734 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.